These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7659841)

  • 21. Bioavailability of drugs: the digoxin dilemma.
    Greenblatt DJ; Smith TW; Koch-Weser J
    Clin Pharmacokinet; 1976; 1(1):36-51. PubMed ID: 797491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digoxin bioavailability: formulations and rates of infusions.
    Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
    Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The assessment of the intrasubject variability in digoxin absorption in man from two oral dosage forms.
    Yacobi A; Stoll RG; Chao GC; Schwartz RA; Weidler DJ; Ayers JW; Sakmar E; Hallmark M; Wagner JG
    J Clin Pharmacol; 1981 Jul; 21(7):301-10. PubMed ID: 7263929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study on digoxin tablets with high bioavailability (author's transl)].
    Flasch CI; Heinz N
    Arzneimittelforschung; 1979; 29(6):961-4. PubMed ID: 582792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption of digoxin from a new microencapsulated formulation.
    Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
    Eur J Clin Pharmacol; 1980 Jun; 17(6):443-7. PubMed ID: 7398735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the interval between feeding and drug administration on oral ampicillin absorption in dogs.
    Küng K; Hauser BR; Wanner M
    J Small Anim Pract; 1995 Feb; 36(2):65-8. PubMed ID: 7723291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
    Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digoxin tablets--a review of the bioavailability problems.
    Sim SK
    Am J Hosp Pharm; 1976 Jan; 33(1):44-8. PubMed ID: 1266866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Absolute bioavailability of beta-acetyldigoxin from tablets and drops in healthy subjects].
    Dreyer M; Dammann HG; Endell W; Rudolph M; Iven H
    Arzneimittelforschung; 1992 Mar; 42(3):303-6. PubMed ID: 1497688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A completely absorbed oral preparation of digoxin.
    Johnson BF; Bye C; Jones G; Sabey GA
    Clin Pharmacol Ther; 1976 Jun; 19(6):746-51. PubMed ID: 1269214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enhanced bioavailability of digoxin by gamma-cyclodextrin complexation: evaluation for sublingual and oral administrations in humans].
    Seo H; Uekama K
    Yakugaku Zasshi; 1989 Oct; 109(10):778-82. PubMed ID: 2621567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of magnesium--aluminum hydroxide and kaolin--pectin on absorption of digoxin from tablets and capsules.
    Allen MD; Greenblatt DJ; Harmatz JS; Smith TW
    J Clin Pharmacol; 1981 Jan; 21(1):26-30. PubMed ID: 7012189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of grapefruit juice on intestinal P-glycoprotein: evaluation using digoxin in humans.
    Parker RB; Yates CR; Soberman JE; Laizure SC
    Pharmacotherapy; 2003 Aug; 23(8):979-87. PubMed ID: 12921244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of induced cholestasis on pharmacokinetics of digoxin and digitoxin in dogs.
    Miyazawa Y; Sato T; Kobayashi K; Akahori F; Suzuki T; Miyashita H
    Am J Vet Res; 1990 Apr; 51(4):605-10. PubMed ID: 2327624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biologic availability of digoxin in soft gelatin capsules and in tablets].
    Merotti GC; Ghirardi P; Marzo A; Parenti MA
    Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1612-4. PubMed ID: 4458749
    [No Abstract]   [Full Text] [Related]  

  • 38. [Bioavailability and elimination of various digoxin preparations in the beagle dog and their possible sex dependence (author's transl)].
    Gastauer R; Eltze M; Pabst J
    Arzneimittelforschung; 1979; 29(5):754-7. PubMed ID: 582973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unchanged absorption of digoxin tablets in patients with cardiac failure.
    Meister W; Benowitz NL; Benet LZ
    Pharmacology; 1984; 28(2):90-4. PubMed ID: 6709691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.